Showing 9,741 - 9,760 results of 30,730 for search '(( 2 step decrease ) OR ( 50 ((((we decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 0.75s Refine Results
  1. 9741

    Anti-tumor effects of X-PACT and its individual components on 4T1-HER2 cells. by Mark Oldham (2577727)

    Published 2016
    “…<p><b>A:</b> cell viability after X-PACT (10μM 8-MOP equivalent dilution of UVADEX, 50μg/mL phosphor, 1Gy of 80kVp radiation) as determined by Guava flow cytometry. …”
  2. 9742
  3. 9743
  4. 9744

    Intermolecular Failure of L-type Ca<sup>2+</sup> Channel and Ryanodine Receptor Signaling in Hypertrophy by Ming Xu (151206)

    Published 2007
    “…<div><p>Pressure overload–induced hypertrophy is a key step leading to heart failure. The Ca<sup>2+</sup>-induced Ca<sup>2+</sup> release (CICR) process that governs cardiac contractility is defective in hypertrophy/heart failure, but the molecular mechanisms remain elusive. …”
  5. 9745

    Study methods flow chart. by Luis Polo-Ferrero (20513578)

    Published 2025
    “…Hormonal changes that occur early in women may influence protein synthesis and promote muscle atrophy, leading to probable sarcopenia, defined as a loss of muscle strength without an obvious decrease in muscle mass. …”
  6. 9746

    Table 1_Effects of different dosages/frequency of Xuebijing injection (a Chinese patent) for sepsis: a network meta-analysis of randomized controlled trials.docx by Guangyan Liu (716821)

    Published 2025
    “…Objective<p>Xuebijing injection (XBJ) has been widely recognized in the treatment of sepsis, however, inadequate information regarding XBJ's optimal dosage and frequency suffice. We aimed to assess the effectiveness of various doses and administration frequencies in patients with sepsis using a network meta-analysis (NMA) to offer therapeutic prescription guidance.…”
  7. 9747
  8. 9748
  9. 9749

    Schematic representation of the possible effects of PARP-1 activation on mTORC1 and mTORC2 components and cell death. by Chantal Éthier (36413)

    Published 2012
    “…S6 phosphorylation may also be affected by the reduced ERK1/2 phosphorylation observed following PAR synthesis. …”
  10. 9750

    A stochastic model for microtubule-dependent movements of human adenovirus. by Mattia Gazzola (255327)

    Published 2009
    “…Equations <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1000623#pcbi.1000623-Greber1" target="_blank">[1]</a>–<a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1000623#pcbi.1000623-Gross1" target="_blank">[6]</a> describe the dynamics of the model: <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1000623#pcbi.1000623-Schliwa1" target="_blank">[3]</a>/<a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1000623#pcbi.1000623-Vale1" target="_blank">[4]</a> dynein binding/unbinding and decrease/increase of the number (ρ) of the available motor binding sites on the virus capsid with d<sub>α</sub>/d<sub>δ</sub> binding/unbinding rates, <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1000623#pcbi.1000623-Welte1" target="_blank">[5]</a>/<a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1000623#pcbi.1000623-Gross1" target="_blank">[6]</a> kinesin binding/unbinding and decrease/increase of the number(ρ) of the available motor binding sites on the virus capsid with k<sub>α/</sub>k<sub>δ</sub> binding/unbinding rates, and <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1000623#pcbi.1000623-Greber1" target="_blank">[1]</a>/<a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1000623#pcbi.1000623-Brandenburg1" target="_blank">[2]</a> dynein/kinesin motor stepping with d<sub>μ</sub>/k<sub>μ</sub> stepping rates. …”
  11. 9751

    Physiological effect of cleavage of periostin by MMP9 on IMCD-3 cell proliferation. by Nabila Djaziri (17537499)

    Published 2023
    “…(B, C) Representative Western Blot and quantitative analysis showing that periostin level is decreased by 50% after incubation with activated MMP9 overnight. …”
  12. 9752

    Table_1_Effectiveness of a protein-supplemented very-low-calorie diet program for weight loss: a randomized controlled trial in South Korea.docx by Eunbyul Cho (12135697)

    Published 2024
    “…Waist circumference (−8.35 cm vs. -4.85 cm; mean difference, −3.49 cm; 95% CI, −6.48 to −0.50) and visceral fat area (−28.28 cm<sup>2</sup> vs. −13.26 cm<sup>2</sup>; mean difference, −15.03cm<sup>2</sup>; 95% CI, −29.01 to −1.04) also significantly decreased in the PSVLCD group at 12 months.…”
  13. 9753
  14. 9754
  15. 9755
  16. 9756

    Table 2_Quantitative proteomic analysis reveals potential serum diagnostic markers for colorectal adenoma.xlsx by Chengli Yu (1445185)

    Published 2025
    “…The alterations in these candidate proteins were further validated by ELISA to evaluate their potential as diagnostic biomarkers for colorectal adenoma.</p>Results<p>In two independent cohorts, we identified two candidate biomarkers, apolipoprotein A4 (APOA4) and filamin A (FLNA), through a multi-step selection process involving ANOVA p-value screening, sparse partial least squares discriminant analysis (sPLS-DA), and LASSO regression analysis. …”
  17. 9757

    A DAG-to-PE route mediated by Bbc may support cell growth in <i>CdsA RNAi</i> fat body. by Yuan Liu (88411)

    Published 2014
    “…Fat storage in the salivary gland of <i>CdsA</i> mutants increases dramatically. Scale bar (A, C, D): 50 µm. …”
  18. 9758

    Data_Sheet_1_Benzyl isothiocyanate ameliorates cognitive function in mice of chronic temporal lobe epilepsy.pdf by Chang Xiaoyu (18426012)

    Published 2024
    “…Conversely, the BITC treatment group, when compared to the EP group, showed enhanced transcription levels of Nrf2, HO-1, and NQO1, along with increased GSH-Px activity, and a decrease in MDA content.…”
  19. 9759

    Discovery of 2‑Aryl-4-aminoquinazolin-Based LSD1 Inhibitors to Activate Immune Response in Gastric Cancer by Bo Wang (86769)

    Published 2024
    “…Novel LSD1 inhibitors with different mechanisms are therefore needed. Herein, we reported a series of novel quinazoline-based LSD1 inhibitors. …”
  20. 9760

    Discovery of In Vivo Active Sphingosine-1-phosphate Transporter (Spns2) Inhibitors by Russell Fritzemeier (5538416)

    Published 2022
    “…While mouse genetic studies suggest that Spns2 functions to maintain lymph S1P, Spns2 inhibitors are necessary to understand its biology and to learn whether Spns2 is a viable drug target. Herein, we report a structure–activity relationship study that identified the first Spns2 inhibitor <b>16d</b> (SLF1081851). …”